1. Home
  2. BMA vs CYTK Comparison

BMA vs CYTK Comparison

Compare BMA & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMA
  • CYTK
  • Stock Information
  • Founded
  • BMA 1966
  • CYTK 1997
  • Country
  • BMA Argentina
  • CYTK United States
  • Employees
  • BMA N/A
  • CYTK N/A
  • Industry
  • BMA Commercial Banks
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMA Finance
  • CYTK Health Care
  • Exchange
  • BMA Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • BMA 5.1B
  • CYTK 6.0B
  • IPO Year
  • BMA 2006
  • CYTK 2004
  • Fundamental
  • Price
  • BMA $96.86
  • CYTK $48.87
  • Analyst Decision
  • BMA Hold
  • CYTK Buy
  • Analyst Count
  • BMA 3
  • CYTK 16
  • Target Price
  • BMA $50.83
  • CYTK $84.07
  • AVG Volume (30 Days)
  • BMA 383.0K
  • CYTK 1.2M
  • Earning Date
  • BMA 11-27-2024
  • CYTK 11-06-2024
  • Dividend Yield
  • BMA 6.10%
  • CYTK N/A
  • EPS Growth
  • BMA 471.05
  • CYTK N/A
  • EPS
  • BMA 0.89
  • CYTK N/A
  • Revenue
  • BMA $2,808,783,625.00
  • CYTK $3,219,000.00
  • Revenue This Year
  • BMA N/A
  • CYTK N/A
  • Revenue Next Year
  • BMA N/A
  • CYTK $795.25
  • P/E Ratio
  • BMA $12.48
  • CYTK N/A
  • Revenue Growth
  • BMA 95.76
  • CYTK N/A
  • 52 Week Low
  • BMA $24.41
  • CYTK $43.21
  • 52 Week High
  • BMA $109.36
  • CYTK $110.25
  • Technical
  • Relative Strength Index (RSI)
  • BMA 60.30
  • CYTK 44.62
  • Support Level
  • BMA $83.12
  • CYTK $45.66
  • Resistance Level
  • BMA $109.36
  • CYTK $49.40
  • Average True Range (ATR)
  • BMA 5.94
  • CYTK 1.71
  • MACD
  • BMA 0.74
  • CYTK -0.20
  • Stochastic Oscillator
  • BMA 54.76
  • CYTK 50.79

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: